Acute effects of fructose consumption on uric acid and plasma lipids in patients with impaired renal function

Metabolism: Clinical and Experimental

Volumn 62, Issue 10, 2013, Pages 1462-1469

  Zawiasa, Anna ^a   Nowicki, Michał ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Calcineurin inhibitors; Chronic kidney disease; Fructose; Kidney transplantation

Indexed keywords

ALDOSTERONE ANTAGONIST; ALLOPURINOL; ANGIOTENSIN RECEPTOR ANTAGONIST; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FRUCTOSE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOOP DIURETIC AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; THIAZIDE DIURETIC AGENT; TRIACYLGLYCEROL; URIC ACID; CHOLESTEROL; IMMUNOSUPPRESSIVE AGENT; LIPID;

ADULT; AREA UNDER THE CURVE; ARTICLE; BODY MASS; CARBOHYDRATE INTAKE; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CLINICAL ASSESSMENT TOOL; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; DISEASE SEVERITY; FEMALE; GLOMERULONEPHRITIS; GLOMERULUS FILTRATION RATE; GRAFT RECIPIENT; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INTERSTITIAL NEPHRITIS; KIDNEY AGENESIS; KIDNEY DYSFUNCTION; KIDNEY DYSPLASIA; KIDNEY FUNCTION; KIDNEY GRAFT; KIDNEY POLYCYSTIC DISEASE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; NEPHROLITHIASIS; ORAL FRUCTOSE TOLERANCE TEST; PRIORITY JOURNAL; PROTEINURIA; RHABDOMYOLYSIS; STEROID THERAPY; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; BLOOD; BLOOD PRESSURE; DRUG EFFECTS; KIDNEY TRANSPLANTATION; MIDDLE AGED; RENAL INSUFFICIENCY; RENAL INSUFFICIENCY, CHRONIC;

ADULT; BLOOD PRESSURE; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; FRUCTOSE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LIPIDS; MALE; MIDDLE AGED; RENAL INSUFFICIENCY; RENAL INSUFFICIENCY, CHRONIC; TRIGLYCERIDES; URIC ACID;

EID: 84884531868     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2013.05.020     Document Type: Article

References (48)

1. B.P. Marriot, N. Cole, and E. Lee National estimates of dietary fructose intake increased from 1977 to 2004 in the United States J Nutr 139 2009 1228S 1235S
2. K.J. Duffey, and B.M. Popkin High-fructose corn syrup: is this what's for dinner? Am J Clin Nutr 88 Suppl 2008 1722S 1732S
3. S.S. Elliott, N.L. Keim, and J.S. Stern Fructose, weight gain and the insulin resistance syndrome Am J Clin Nutr 77 2002 911 922
4. J.W.J. Choi, E.S. Ford, and X. Gao Sugar-sweetened soft drinks, diet soft drinks and serum uric acid level: The Third National Health and Nutrition Examination Survey Arthritis Rheum 59 2008 109 116
5. X. Gao, L. Qi, and N. Qiao Intake of added sugar and sugar-sweetened drink and serum uric acid concentration in US men and women Hypertension 50 2007 306 312
6. T. Nakagawa, K.R. Tuttle, and R.A. Short Hypothesis: fructose-induced hyperuricemia as a causal mechanism for the epidemic of the metabolic syndrome Nat Clin Pract Nephrol 1 2005 80 86
7. M.J. Dekker, Q. Su, and C. Baker Fructose: a highly lipogenic nutrient implicated in insulin resistance, hepatic steatosis, and the metabolic syndrome Am J Physiol Endocrinol Metab 299 2010 E685 E694
8. M. Kretowicz, R.J. Johnson, and T. Ishimoto The impact of fructose on renal function and blood pressure Int J Nephrol 2011 2011 315879 http://dx.doi.org/10.4061/2011/315879
9. D.I. Jalal, G. Smits, and R.J. Johnson Increased fructose associates with elevated blood pressure J Am Soc Nephrol 21 2010 1543 1549
10. M. Madero, S.E. Perez-Pozo, and D. Jalal Dietary fructose and hypertension Curr Hypertens Rep 13 2011 29 35
11. R.J. Johnson, G.L. Sanchez-Lozada, and T. Nakagawa The effect of fructose on renal biology and disease J Am Soc Nephrol 21 2010 2036 2039
12. S. van der Zee, U. Baber, and S. Elmariah Cardiovascular risk factors in patients with chronic kidney disease Nat Rev Cardiol 6 2009 580 589
13. Y.F. Vanrenterghem, K. Claes, and Montagnino Risk factors for cardiovascular events after successful renal transplantation Transplantation 85 2008 209 216
14. A.D. Slee Exploring metabolic dysfunction in chronic kidney disease Nutr Metab (Lond). 9 2012 36 52
15. D.I. Jalal, M. Chonchol, and W. Chen Uric acid as a target of therapy in CKD Am J Kidney Dis 61 2013 134 146
16. L. Liefeldt, and K. Budde Risk factors for cardiovascular disease in renal transplant recipients and strategies to minimize risk Transpl Int 23 2010 1191 1204
17. C. Ponticelli, D. Cucchiari, and G. Graziani Hypertension in kidney transplant recipients Transpl Int 24 2011 523 533
18. E. Akalin, S.V. Ganeshan, and J. Winston Hyperuricemia is associated with the development of the composite outcomes of new cardiovascular events and chronic allograft nephropathy Transplantation 86 2008 652 658
19. V. Filiopoulos, D. Hadjiyannakos, and D. Vlassopoulos New insights into uric acid effects on the progression and prognosis of chronic kidney disease Ren Fail 34 2012 510 520
20. Y.P. Siu, K.T. Leung, M.K. Tong, and T.H. Kwan Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level Am J Kidney Dis 47 2006 51 59
21. M. Kanbay, A. Ozkara, and Y. Selcoki Effect of treatment of hyperuricemia with allopurinol on blood pressure, creatinine clearance, and proteinuria in patients with normal renal functions Int Urol Nephrol 39 2007 1227 1233
22. D.I. Feig, D.H. Kang, and R.J. Johnson Uric acid and cardiovascular risk N Engl J Med 359 2008 1811 1821
23. A. Dehghan, M. van Hoek, and E.J. Sijbrands High serum uric acid as a novel risk factor for type 2 diabetes Diabetes Care 31 2008 361 362
24. R.J. Johnson, S.E. Perez-Pozo, and Y.Y. Sautin Hypothesis: could excessive fructose intake and uric acid cause type 2 diabetes? Endocr Rev 30 2009 96 116
25. M.J. Bos, P.J. Koudstaal, and A. Hofman Uric acid is a risk factor for myocardial infarction and stroke: the Rotterdam study Stroke 37 2006 1503 1507
26. F.C. Mazali, and M. Mazzali Uric acid and transplantation Semin Nephrol 31 2011 466 471
27. J. Malheiro, M. Almeida, and I. Fonseca Hyperuricemia in adult renal allograft recipients: prevalence and predictors Transplant Proc 44 2012 369 2372
28. F.C. Mazali, R.J. Johnson, and M. Mazzali Use of uric acid-lowering agents limits experimental cyclosporine nephropathy Nephron Exp Nephrol 120 2012 e12 e19
29. U. Gerhardt, M. Grosse Hüttmann, and H. Hohage Influence of hyperglycemia and hyperuricemia on long-term transplant survival in kidney transplant recipients Clin Transplant 13 1999 375 379
30. A. Haririan, J.M. Nogueira, and K. Zandi-Nejad The independent association between serum uric acid and graft outcomes after kidney transplantation Transplantation 89 2010 573 579
31. T. Akhavan, and G.H. Anderson Effects of glucose-to-fructose ratios in solutions on subjective satiety, food intake, and satiety hormones in young men Am J Clin Nutr 86 2007 1354 1363
32. S.E. Perez-Pozo, J. Schold, and T. Nakagawa Excessive fructose intake induces the features of metabolic syndrome in healthy adult men: role of uric acid in the hypertensive response Int J Obes 34 2010 454 461
33. K.L. Teff, J. Grudziak, and R.R. Townsend Endocrine and metabolic effects of consuming fructose- and glucose-sweetened beverages with meals in obese men and women: influence of insulin resistance on plasma triglyceride responses J Clin Endocrinol Metab 94 2009 1562 1569
34. B. Anderstam, A.C. Bragfors-Helin, and J. Axelsson Differences in acute metabolism of fructose between hemodialysis patients and healthy subjects Scand J Clin Lab Invest 73 2013 154 160
35. A. Zawiasa, M. Szklarek-Kubicka, and J. Fijałkowska-Morawska Effect of oral fructose load on serum uric acid and lipids in kidney transplant recipients treated with cyclosporine or tacrolimus Transplant Proc 41 2009 188 191
36. S. Badiou, J.P. Cristol, and G. Mourad Dyslipidemia following kidney transplantation: diagnosis and treatment Curr Diab Rep 9 2009 305 311
37. M. Boratyńska, M. Banasik, and E. Watorek Influence of hypercholesterolemia and acute graft rejection on chronic nephropathy development in renal transplant recipients Transplant Proc 35 2003 2209 2212
38. H. Hohage, U. Hillebrandt, and U. Welling Cyclosporine and tacrolimus: influence on cardiovascular risk factors Transplant Proc 37 2005 1036 1038
39. J.P. Bantle, S.K. Raatz, and W. Thomas Effects of dietary fructose on plasma lipids in healthy subjects Am J Clin Nutr 72 2000 1128 1134
40. K.L. Stanhope, S.C. Griffen, and B.R. Bair Twenty-four-hour endocrine and metabolic profiles following consumption of high-fructose corn syrup-, sucrose-, fructose-, and glucose-sweetened beverages with meals Am J Clin Nutr 87 2008 1194 1203
41. M.M. Swarbrick, K.L. Stanhope, and S.S. Elliott Consumption of fructose-sweetened beverages for 10 weeks increases postprandial triacylglycerol and apolipoprotein-B concentrations in overweight and obese women Br J Nutr 100 2008 947 952
42. W.T. Gibson, and M.R. Hayden Mycophenolate mofetil and atherosclerosis: results of animal and human studies Ann N Y Acad Sci 1110 2007 209 221
43. C.M. Brown, A.G. Dulloo, and G. Yepuri Fructose ingestion acutely elevates blood pressure in healthy young humans Am J Physiol Regul Integr Comp Physiol 294 2008 R730 R737
44. M.T. Le, R.F. Frye, and C.J. Rivard Effects of high-fructose corn syrup and sucrose on the pharmacokinetics of fructose and acute metabolic and hemodynamic responses in healthy subjects Metabolism 61 2012 641 651
45. A.K. Singh, H. Amlal, and P.J. Haas Fructose-induced hypertension: essential role of chloride and fructose absorbing transporters PAT1 and Glut5 Kidney Int 74 2008 438 447
46. H.M. Wadei, and S.C. Textorb Hypertension in the kidney transplant recipient Transplant Rev 24 2010 105 120
47. I.H. Klein, A. Abrahams, and T. van Ede Different effects of tacrolimus and cyclosporine on renal hemodynamics and blood pressure in healthy subjects Transplantation 73 2002 732 736
48. M. Madero, J.C. Arriaga, and D. Jalal The effect of two energy-restricted diets, a low-fructose diet versus a moderate natural fructose diet, on weight loss and metabolic syndrome parameters: a randomized controlled trial Metabolism 60 2011 1551 1559